Quotient BioResearch acquires BioDynamics

Newmarket, UK-based Quotient BioResearch, a European provider of analytical and safety evaluation services and products for bioscience and sport, has acquired BioDynamics Research.

Founded over 15 years ago, BioDynamics is a leading, specialist provider of metabolism, bioanalytical and radiochemistry services to the worldwide pharmaceutical and biotechnology industries, and has annual revenues of over L7.0 million ($13.6 million) and 100 employees.

This represents the fourth acquisition to date for Quotient BioResearch, which was established in early 2007. The enlarged group will have revenues of over L35.0 million and employ approximately 350 people in the UK. The group will continue to operate from its existing sites in Newmarket, Rushden, London and Edinburgh.